An international research team led by Frank Bosmans of Vrije Universiteit Brussel has identified a significant genetic cause of hyperhidrosis, the condition characterized by chronic and excessive sweating. Published in Science Advances, the findings demonstrate that genetically determined hyperhidrosis results from overstimulation of the nerves controlling sweat glands, offering potential for targeted treatments using existing medicines and removing stigma surrounding the condition.
Hyperhidrosis affects an estimated 2 to 5% of the population, though its severity extends far beyond simple discomfort. Patients sweat so profusely they must change clothes multiple times daily. Many avoid social contact and report feeling deeply ashamed, with some developing depression. Despite these serious consequences, the condition is frequently dismissed as merely a cosmetic issue, leaving patients without proper understanding or appropriate care.
After a decade of research collaborating with Johns Hopkins University, Bosmans' team analyzed DNA from more than 180 patients and discovered defects in the Nav1.8 ion channel, a specific protein channel in the nervous system. This channel normally functions as a biological gate regulating electrical signals. In hyperhidrosis patients, genetic predisposition leaves this gate too wide open, causing constant overstimulation of the nervous system that controls sweat glands. The result is perpetual nerve activity producing excessive sweating, often triggered by emotional or stress-related stimuli without being psychologically based.
Search Antibodies Search Now Use our Antibody Search Tool to find the right antibody for your research. Filter
by Type, Application, Reactivity, Host, Clonality, Conjugate/Tag, and Isotype.
To test their theory, researchers developed an experimental model using mice, which sweat only from their paws. After two years creating a microscopic measurement method using an iodine-starch mixture to count sweat droplets, they confirmed that mice with the same genetic defect sweated excessively. When administered a substance blocking the overactive nerve signals, sweating decreased significantly and reversibly.
The researchers discovered additional complexity when they identified a patient with an "inhibitory" nerve mutation but excessive sweating due to an additional unique mutation in a local water channel within the sweat gland itself. This demonstrates that different biological pathways can lead to the same overstimulation appearing on the skin.
Current severe hyperhidrosis treatment sometimes involves invasive procedures severing sympathetic nerve pathways in the chest. Understanding the biological cause may help predict which patients benefit most from localized sweat gland treatment, systemic medication, or nerve-targeted therapies. Research into existing medicines proved promising in mouse models, particularly agents affecting cholinergic signaling and nerve cell excitability. This mechanism-based approach shifts hyperhidrosis management away from symptomatic treatment toward addressing underlying biological causes, offering patients genuine hope for managing this serious disorder.